Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

ROCURONIUM 50 MG/5 ML VIAL

rocuronium bromide
$0.3942per ML

Strength

50 mg/5mL

Manufacturer

Solco Healthcare US LLC

NDC

43547053010

Classification

Generic

Dosage Form

INJECTION

Route

INTRAVENOUS

Last Updated

4/22/2026

Active Ingredients

ROCURONIUM BROMIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA212668

On Market Since

7/25/2021

Pharmacological Classes

Neuromuscular Nondepolarizing Blockade
Nondepolarizing Neuromuscular Blocker

Price History

1W

0.0%

1M

0.0%

3M

-25.0%

6M

-25.0%

1Y

-25.0%

3Y

N/A

5Y

N/A

All

-26.7%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

ROCURONIUM 50 MG/5 ML VIAL
Generic
00143925010•Hikma Pharmaceuticals USA Inc.
$0.3942
per ML
ROCURONIUM 50 MG/5 ML VIAL
Generic
00409955805•Hospira Inc.
$0.3942
per ML
ROCURONIUM 50 MG/5 ML VIAL
Generic
00409955849•Hospira Inc.
$0.3942
per ML
ROCURONIUM 50 MG/5 ML VIAL
Generic
00781322095•Sandoz Inc.
$0.3942
per ML
ROCURONIUM 50 MG/5 ML VIAL
Generic
25021068705•Sagent Pharmaceuticals
$0.3942
per ML
ROCURONIUM 50 MG/5 ML VIAL
Generic
43066000710•Baxter Healthcare Corporation
$0.3942
per ML
ROCURONIUM 50 MG/5 ML VIAL
Generic
55150022505•Eugia US LLC
$0.3942
per ML
ROCURONIUM 50 MG/5 ML VIAL
Generic
63323042605•Fresenius Kabi USA, LLC
$0.3942
per ML
ROCURONIUM 50 MG/5 ML VIAL
Generic
63323042615•Fresenius Kabi USA, LLC
$0.3942
per ML
ROCURONIUM 50 MG/5 ML VIAL
Generic
65145013010•Caplin Steriles Limited
$0.3942
per ML

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy